SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-037073
Filing Date
2024-08-13
Accepted
2024-08-13 16:13:03
Documents
15
Period of Report
2024-08-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20034050x2_8k.htm   iXBRL 8-K 32989
2 EXHIBIT 5.1 ny20034050x2_ex5-1.htm EX-5.1 10266
3 EXHIBIT 10.1 ny20034050x2_ex10-1.htm EX-10.1 302874
  Complete submission text file 0001140361-24-037073.txt   547107

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20240813.xsd EX-101.SCH 3871
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20240813_lab.xml EX-101.LAB 21966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20240813_pre.xml EX-101.PRE 16048
18 EXTRACTED XBRL INSTANCE DOCUMENT ny20034050x2_8k_htm.xml XML 4069
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 241201599
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)